This is seen as a positive development as it removes the potential reluctance to give a referral because of cost saving measures by the GP and Clinical Commissioning Group (CCG).  LPLD is included in the list of conditions to be tested for.

This is seen as a positive development as it removes the potential reluctance to give a referral because of cost saving measures by the GP and Clinical Commissioning Group (CCG).  LPLD is included in the list of conditions to be tested for.

National Genomic 2018/2019 Genetic Test Directory FAQs

Read more FCS news